Last reviewed · How we verify

sevoflurane-sufentanil balanced — Competitive Intelligence Brief

sevoflurane-sufentanil balanced (sevoflurane-sufentanil balanced) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Balanced anesthetic combination. Area: Anesthesiology.

marketed Balanced anesthetic combination GABA receptors (sevoflurane); mu-opioid receptors (sufentanil) Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

sevoflurane-sufentanil balanced (sevoflurane-sufentanil balanced) — Konkuk University Medical Center. A balanced anesthetic combination that pairs sevoflurane (volatile anesthetic) with sufentanil (opioid) to produce general anesthesia through CNS depression and analgesia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
sevoflurane-sufentanil balanced TARGET sevoflurane-sufentanil balanced Konkuk University Medical Center marketed Balanced anesthetic combination GABA receptors (sevoflurane); mu-opioid receptors (sufentanil)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Balanced anesthetic combination class)

  1. Konkuk University Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). sevoflurane-sufentanil balanced — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-sufentanil-balanced. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: